-
1
-
-
0020555732
-
Amyloidosis (AL). Clinical and laboratory features in 229 cases
-
KYLE RA, GREIPP PR: Amyloidosis (AL) Clinical and laboratory features in 229 cases. Mayo Clin Proc 58:665-683, 1983
-
(1983)
Mayo Clin Proc
, vol.58
, pp. 665-683
-
-
Kyle, R.A.1
Greipp, P.R.2
-
2
-
-
0028970456
-
Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
-
KYLE RA, GERTZ MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 32:45-59, 1995
-
(1995)
Semin Hematol
, vol.32
, pp. 45-59
-
-
Kyle, R.A.1
Gertz, M.A.2
-
3
-
-
0030895545
-
A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine
-
KYLE RA, GERTZ MA, GREIPP PR, et al: A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336:1202-1207, 1997
-
(1997)
N Engl J Med
, vol.336
, pp. 1202-1207
-
-
Kyle, R.A.1
Gertz, M.A.2
Greipp, P.R.3
-
4
-
-
0026474596
-
Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients
-
GERTZ MA, KYLE RA, O'FALLON WM: Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 152:2245-2250, 1992
-
(1992)
Arch Intern Med
, vol.152
, pp. 2245-2250
-
-
Gertz, M.A.1
Kyle, R.A.2
O'Fallon, W.M.3
-
5
-
-
0029939944
-
Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only
-
SKINNER M, ANDERSON J, SIMMS R, et al: Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100:290-298, 1996
-
(1996)
Am J Med
, vol.100
, pp. 290-298
-
-
Skinner, M.1
Anderson, J.2
Simms, R.3
-
6
-
-
0033630225
-
The systemic amyloidoses: An overview
-
FALK RH, SKINNER M: The systemic amyloidoses: An overview. Adv Intern Med 45:107-137, 2000
-
(2000)
Adv Intern Med
, vol.45
, pp. 107-137
-
-
Falk, R.H.1
Skinner, M.2
-
7
-
-
0019353039
-
Presentation and course of primary amyloidosis of the kidney
-
OGG CS, CAMERON JS, WILLIAMS DG, TURNER DR: Presentation and course of primary amyloidosis of the kidney. Clin Nephrol 15:9-13, 1981
-
(1981)
Clin Nephrol
, vol.15
, pp. 9-13
-
-
Ogg, C.S.1
Cameron, J.S.2
Williams, D.G.3
Turner, D.R.4
-
8
-
-
0032525180
-
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: Survival and responses in 25 patients
-
COMENZO RL, VOSBURGH E, FALK RH, et al: Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: Survival and responses in 25 patients. Blood 91:3662-3670, 1998
-
(1998)
Blood
, vol.91
, pp. 3662-3670
-
-
Comenzo, R.L.1
Vosburgh, E.2
Falk, R.H.3
-
9
-
-
0032986336
-
Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis
-
COMENZO RL, SANCHORAWALA V, FISHER C, et al: Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol 104:553-559, 1999
-
(1999)
Br J Haematol
, vol.104
, pp. 553-559
-
-
Comenzo, R.L.1
Sanchorawala, V.2
Fisher, C.3
-
10
-
-
0034747773
-
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
-
SANCHORAWALA V, WRIGHT DG, SELDIN DC, et al: An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant 28:637-642, 2001
-
(2001)
Bone Marrow Transplant
, vol.28
, pp. 637-642
-
-
Sanchorawala, V.1
Wright, D.G.2
Seldin, D.C.3
-
11
-
-
0035340870
-
Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease
-
DEMBER LM, SANCHORAWALA V, SELDIN DC, et al: Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease. Ann Intern Med 134:746-753, 2001
-
(2001)
Ann Intern Med
, vol.134
, pp. 746-753
-
-
Dember, L.M.1
Sanchorawala, V.2
Seldin, D.C.3
-
12
-
-
0026034817
-
Response rates and survival in primary systemic amyloidosis
-
GERTZ MA, KYLE RA, GREIPP PR: Response rates and survival in primary systemic amyloidosis. Blood 77:257-262, 1991
-
(1991)
Blood
, vol.77
, pp. 257-262
-
-
Gertz, M.A.1
Kyle, R.A.2
Greipp, P.R.3
-
13
-
-
0034012359
-
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report
-
GERTZ MA, LACY MQ, DISPENZIERI A: Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: A status report. Bone Marrow Transplant 25:465-470, 2000
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 465-470
-
-
Gertz, M.A.1
Lacy, M.Q.2
Dispenzieri, A.3
-
15
-
-
0000594647
-
High-dose melphalan and stem cell rescue for AL amyloidosis
-
edited by Kyle R, Gertz M, Pearl River, New York, Parthenon Publishing
-
GILLMORE J, APPERLEY J, CRADDOCK C: High-dose melphalan and stem cell rescue for AL amyloidosis, in Amyloid and Amyloidosis 1998, edited by KYLE R, GERTZ M, Pearl River, New York, Parthenon Publishing, 1999, pp 102-104
-
(1999)
Amyloid and Amyloidosis 1998
, pp. 102-104
-
-
Gillmore, J.1
Apperley, J.2
Craddock, C.3
-
16
-
-
7144251173
-
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report on 21 patients
-
MOREAU P, LEBLOND V, BOURQUELOT P, et al: Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report on 21 patients. Br J Haematol 101:766-769, 1998
-
(1998)
Br J Haematol
, vol.101
, pp. 766-769
-
-
Moreau, P.1
Leblond, V.2
Bourquelot, P.3
-
17
-
-
0034799598
-
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
-
BADROS A, BARLOGIE B, SIEGEL E, et al: Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol 114:822-829, 2001
-
(2001)
Br J Haematol
, vol.114
, pp. 822-829
-
-
Badros, A.1
Barlogie, B.2
Siegel, E.3
-
18
-
-
0033920690
-
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
-
TOSI P, ZAMAGNI E, RONCONI S, et al: Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. Leukemia 14:1310-1313, 2000
-
(2000)
Leukemia
, vol.14
, pp. 1310-1313
-
-
Tosi, P.1
Zamagni, E.2
Ronconi, S.3
|